|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.48 USD | +6.87% |
|
+10.25% | +29.18% |
| Market Cap | 3.3B 2.91B 2.68B 2.51B 4.7B 311B 4.79B 32.25B 12.49B 154B 12.41B 12.14B 535B | P/E 2026 * |
-7.57x | P/E 2027 * | -7.25x |
|---|---|---|---|---|---|
| Enterprise Value | 2.45B 2.16B 1.99B 1.86B 3.49B 231B 3.55B 23.91B 9.26B 114B 9.2B 9B 396B | EV / Sales 2026 * |
33.5x | EV / Sales 2027 * | 24.4x |
| Free-Float |
98.64% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Beam Therapeutics Inc.
| 1 day | +6.96% | ||
| 1 week | +10.25% | ||
| Current month | +8.75% | ||
| 1 month | +20.21% | ||
| 3 months | +49.52% | ||
| 6 months | +27.26% | ||
| Current year | +29.18% |
| 1 week | 32.66 |  | 36.88 |
| 1 month | 28.3 | | 36.88 |
| Current year | 21.63 | | 36.88 |
| 1 year | 15.6 | | 36.88 |
| 3 years | 13.52 | | 49.5 |
| 5 years | 13.52 | | 138.52 |
| 10 years | 13 | | 138.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Evans
CEO | Chief Executive Officer | 48 | 2016-12-31 |
Sravan Emany
DFI | Director of Finance/CFO | 48 | 2024-12-18 |
| President | 57 | 2020-01-23 |
| Director | Title | Age | Since |
|---|---|---|---|
John Evans
BRD | Director/Board Member | 48 | 2016-12-31 |
Mark Fishman
BRD | Director/Board Member | 75 | 2018-04-30 |
Graham Cooper
BRD | Director/Board Member | 56 | 2019-10-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Fiscal year | Chairperson | 71,010 | 0.0690% | ||
| 06-02 | Free | Director | 19,676 | 0.0191% | ||
| 06-02 | Free | Director | 19,676 | 0.0191% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.00% | +10.25% | +108.80% | +12.01% | 3.3B | |
| +2.56% | +7.12% | -7.30% | +1.26% | 44.45B | |
| -0.53% | +6.99% | +321.68% | +578.73% | 36.04B | |
| +1.23% | +6.70% | +5.05% | +55.63% | 30.7B | |
| +7.34% | +7.69% | +15.90% | -14.04% | 28.59B | |
| +7.60% | -1.03% | +14.05% | +20.82% | 23.01B | |
| +0.02% | +3.55% | - | - | 14.82B | |
| +7.16% | +10.95% | +60.85% | +125.28% | 13.52B | |
| +2.73% | +7.16% | +11.00% | +19.38% | 12.98B | |
| +0.82% | +3.03% | +93.15% | +95.82% | 12.56B | |
| Average | +3.58% | +3.31% | +69.24% | +99.43% | 22B | |
| Weighted average by Cap. | +3.08% | +3.17% | +71.64% | +126.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 73.19M 64.43M 59.43M 55.59M 104M 6.9B 106M 714M 277M 3.4B 275M 269M 11.84B | 87.27M 76.84M 70.87M 66.28M 124M 8.23B 127M 852M 330M 4.06B 328M 321M 14.12B |
| Net income | -465M -409M -377M -353M -661M -43.81B -674M -4.54B -1.76B -21.61B -1.75B -1.71B -75.19B | -521M -458M -423M -395M -741M -49.07B -755M -5.08B -1.97B -24.21B -1.95B -1.91B -84.22B |
| Net Debt | -855M -752M -694M -649M -1.22B -80.55B -1.24B -8.34B -3.23B -39.73B -3.21B -3.14B -138B | -1.17B -1.03B -952M -890M -1.67B -110B -1.7B -11.44B -4.43B -54.49B -4.4B -4.3B -190B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-24 | US$35.75 | +7.68% | 1,368,319 |
| 26-06-23 | US$33.20 | -6.56% | 3,604,536 |
| 26-06-22 | US$35.53 | +4.07% | 2,603,285 |
| 26-06-18 | US$34.14 | +5.11% | 3,509,471 |
| 26-06-17 | US$32.48 | +4.81% | 2,174,739 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BEAM Stock
Select your edition
All financial news and data tailored to specific country editions
